Position in ESPR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
3,930,125
+22.8% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $319,058,775 across 7 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
2,646,201 | $123,074,808 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
535,838 | $90,310,136 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
13,932,000 | $58,653,720 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
336,000 | $15,882,720 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,958,702 | $15,512,919 | |
| 6 | EOLS |
Evolus, Inc.
|
1,436,000 | $9,965,840 | |
| 7 | CTOR |
Citius Oncology, Inc.
|
8,705,589 | $5,658,632 |
All Filings in ESPR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 3,930,125 | Shares | Sole | 2026-05-15 | |
| 2023-12-31 | — | 3,200,000 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | — | 9,193,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | — | 3,679,279 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||